Instrumente de accesibilitate
Selector de limbi
II - Reprezentanți interni cu activități de lobby și asociații comerciale/de întreprinderi/profesionale
Companii şi grupuri
Riverwalk; Citywest Business Campus, 5
(+353) 1 429 7700
Domnul Flemming Ornskov
Chief Executive Officer
Domnul Emmanuel Chantelot
Head of International Government Relations & Public Affairs
Shire is an international specialty biopharmaceutical company focused on a single purpose: to enable people with life-altering conditions to lead better lives.
Shire focuses its business on rare diseases, neuroscience, gastrointestinal conditions and internal medicine.
Pharmaceutical sector policies
Rare Disease policies
Mental Health policies
European Commission's annual work programme
European Medicines Agency
Shire engages in debates on issues relevant to the biopharmaceutical sector. Shire supports equal access to innovative medicines in Europe and research and innovation in the healthcare sector.
Shire also interacts with the EU Institutions in relation to legislation which has impact on the industry, for example Shire participates in relevant public consultations.
75%: 1 50%: 1 25%: 3
5 persons involved are 3 Shire employees (at 75%, 50% and 25% FTE respectively) and 2 external consultants (at 25% FTE respectively).
|Nicio persoană acreditată|
Shire is a member of the European Association of Bioindustries (EuropaBio), European Federation of Pharmaceutical Industries and Associations (EFPIA), and the American Chamber of Commerce to the European Union (AmCham EU).
01/2014 - 12/2014
Nu am primit finanțare din partea instituțiilor UE în cursul ultimului exercițiu financiar încheiat.
Employees (1.5 FTE total within scope of register activities) = EUR 240,000
Public Affairs consultancy fees = EUR 250,000
Trade Association membership fees = EUR 95,000
Cost of policy events and publications = EUR 100,000
Office & administrative expenses = EUR 15,000
Înregistrându-se, organizaţia a semnat Codul de conduită al Registrului de transparenţă.